cromolyn sodium has been researched along with Cryptogenic Fibrosing Alveolitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agrawal, S; Birring, SS; Maher, TM; Morice, AH; Stone, H; Tutuncu, A; van den Berg, JWK; Wijsenbeek, MS | 1 |
1 trial(s) available for cromolyn sodium and Cryptogenic Fibrosing Alveolitis
| Article | Year |
|---|---|
A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial.
Topics: Administration, Inhalation; Adult; Aged; Anti-Asthmatic Agents; Chronic Disease; Cough; Cromolyn Sodium; Cross-Over Studies; Double-Blind Method; Female; Humans; Idiopathic Pulmonary Fibrosis; Lung; Male; Middle Aged; Nebulizers and Vaporizers; Netherlands; Pilot Projects; Proof of Concept Study; Treatment Outcome; United Kingdom; Young Adult | 2017 |